Stem Cell Rev. 2009 Sep;5(3):278-82. Epub 2009 May 27. Present status and perspectives of stem cell-based therapies for gastrointestinal diseases. Yan L, Cai C, Li J, Xu S, Chang Q, Li Y, Wu B. Gastrointestinal Department of Southern Building, PLA general hospital, Beijing, China. Abstract In recent years the interest in stem cell-based therapies for…

Mol Ther. 2010 Jul;18(7):1365-72. Epub 2010 Apr 13. Targeting improves MSC treatment of inflammatory bowel disease. Ko IK, Kim BG, Awadallah A, Mikulan J, Lin P, Letterio JJ, Dennis JE. Source Department of Orthopedics, Case Western Reserve University, Cleveland, Ohio, USA. Abstract Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is an…

Gastroenterology. 2007 Mar;132(3):944-54. Epub 2006 Dec 19. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, Mutschler WE, Siebeck M, Huss R. Source Department of Surgery, Klinikum Innenstadt, Ludwig-Maximilians-Universität of München, Munich, Germany. philipe.khalil@med.uni-muenchen.de Abstract BACKGROUND AND AIMS: Reduced microcirculation…

Biochem Biophys Res Commun. 2007 Oct 5;361(4):953-9. Epub 2007 Aug 1. Embryonic stem cells ameliorate piroxicam-induced colitis in IL10-/- KO mice. Srivastava AS, Feng Z, Mishra R, Malhotra R, Kim HS, Carrier E. Source Department of Medicine, University of California Irvine, CA 92697, USA. Abstract The primary objective of this work is to determine the…

Dis Colon Rectum. 2009 Jan;52(1):79-86. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M. Source Department of Surgery and Cell Therapy, La Paz University Hospital, Universidad Autónoma de Madrid, Madrid,…

Ter Arkh. 2010;82(2):38-43. Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases. [Article in Russian] Lazebnik LB, Konopliannikov AG, Kniazev OV, Parfenov AI, Tsaregorodtseva TM, Ruchkina IN, Khomeriki SG, Rogozina VA, Konopliannikova OA. Abstract AIM: to determine the whether mesenchymal stem cells (MSC) may be used in the treatment of patients…

Eksp Klin Gastroenterol. 2010;(3):5-10. Transplantation of allogeneic mesenchymal stem cells from the bone marrow increases duration of remission and reduces the risk of ulcerative colitis relapse. [Article in Russian] Lazebnik LB, Kniazev OV, Parfenov AI, Ruchkina IN, Rogozina VA, Konopliannikov AG. Abstract The first results of allogeneic mesenchymal stem cells from the bone marrow transplantation…

Blood. 2010 Dec 23;116(26):6123-32. Epub 2010 Sep 13. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Burt RK, Craig RM, Milanetti F, Quigley K, Gozdziak P, Bucha J, Testori A, Halverson A, Verda L, de Villiers WJ, Jovanovic B, Oyama Y. Source Division of Immunotherapy, Department of…

Gut. 2011 Jun;60(6):788-98. Epub 2011 Jan 21. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A, Calliada F, Dionigi P, Perotti C, Locatelli F, Corazza GR. Source Clinica Medica I, Fondazione IRCCS Policlinico…

Front Biosci (Schol Ed). 2010 Jun 1;2:993-1008. Stem cells as potential therapeutic targets for inflammatory bowel disease. Singh UP, Singh NP, Singh B, Mishra MK, Nagarkatti M, Nagarkatti PS, Singh SR. Source Pathology and Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29208, USA. Abstract The incidence and prevalence of Crohn’s…